Premium
P3‐009: Study Design and Characteristics of Two Phase II Proof‐of‐Concept Clinical Trials of the PDE9 Inhibitor BI 409306 in Early Alzheimer's Disease
Author(s) -
Wunderlich Glen,
Thamer Claus,
Roehrle Michael,
Garcia Miguel,
Frölich Lutz,
Dubois Bruno
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.1666
Subject(s) - placebo , clinical trial , donepezil , clinical dementia rating , clinical endpoint , medicine , randomized controlled trial , dementia , alzheimer's disease , rating scale , psychology , physical therapy , disease , pathology , alternative medicine , developmental psychology